Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06776367 · ClinicalTrials.gov registry record

Project REMOTE (REimagining Measurements and Operations of Translational Endpoints)

A clinical trial of COVID-19, sponsored by Biomedical Advanced Research and Development Authority.

Active
Registry status
4,000
Enrollment target
16
Study locations

NCT06776367 is a study of COVID-19 that is active but no longer recruiting, run by Biomedical Advanced Research and Development Authority. The registered enrollment target is 4,000 participants, below the 55,195-participant average among 203 other COVID-19 trials with a reported enrollment target (93% lower). The trial reports 16 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06776367, a study of COVID-19, is active but no longer recruiting, sponsored by Biomedical Advanced Research and Development Authority.

ACTIVE NOT RECRUITING
Registry status
4,000 participants
Enrollment target
16
Study locations

Study Summary

This trial is designed to assess immunological biomarkers measured from blood samples that can be used to reliably predict how well vaccines work against symptomatic COVID-19 as well as to evaluate the feasibility of remote, self-collected specimens when conducting a correlates analysis. For a lot of research studies, people need to go to the study doctor's office regularly. For this study, we want to see if it is okay that people do the study doctor visits virtually, fill out questionnaires electronically, and collect their own samples remotely. Participants will enroll in the study after receiving a COVID-19 vaccine in their community, and saliva and blood specimens will be collected at pre-defined time-points over a 12-month period. Additionally, participants will report weekly whether they experience symptoms of COVID-19, and if so, will be prompted to collect a nasal swab for testing. Most participants will complete all activities remotely and via electronic communications, but a small number will complete activities in person at the doctor's office to provide a comparison group. Samples from the study will be analyzed to determine whether the biomarkers can be measured, and data from the study will be used to evaluate the feasibility of doing the specimen and data collection without the participant going to the doctor's office in person.

Conditions Studied

COVID-19

Interventions

  • OTHER Remote study participation and self-collection of specimens
  • OTHER Traditional clinical trial participation with clinician-collected specimens

Study Locations (16)

California

  • Apex Research Group - Fair Oaks
  • Wake Research Encino - Los Angeles
  • Wake Research San Diego - San Diego

Georgia

  • Emory University - Atlanta
  • Wake Research Atlanta - Atlanta

Alabama

  • Accel Research Site Networks - Birmingham CRU / Elite - Vestavia Hills

Arizona

  • Desert Clinical Research - Mesa

Florida

  • Research Institute of South Florida - Miami

Kansas

  • Johnson County Clinical Trials (JCCT) - Lenexa

Kentucky

  • Research Integrity / WCG - Owensboro

Massachusetts

  • Alcanza / hyperCORE - Boston

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2024-12-20
Est. Completion 2026-07

Sponsor

Biomedical Advanced Research and Development Authority

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06776367

The ClinicalTrials.gov registry entry for NCT06776367 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,195-participant average among 203 other COVID-19 trials with a reported enrollment target (93% lower). The listed sponsor is Biomedical Advanced Research and Development Authority, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Remote study participation and self-collection of specimens is the first listed.

NCT06776367 reports 16 study locations spanning 13 distinct geographic areas - top geographies include California, Georgia, Alabama.

Frequently Asked Questions

What is clinical trial NCT06776367 about?

NCT06776367 is a clinical study titled "Project REMOTE (REimagining Measurements and Operations of Translational Endpoints)". This trial is designed to assess immunological biomarkers measured from blood samples that can be used to reliably predict how well vaccines work against symptomatic COVID-19 as well as to evaluate the feasibility of remote, self-collected specimens when conducting a correlates analysis. For a lot o...

What is the current status of trial NCT06776367?

This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2024-12-20. Estimated completion is 2026-07.

What conditions does trial NCT06776367 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT06776367?

The interventions under investigation include: Remote study participation and self-collection of specimens (OTHER), Traditional clinical trial participation with clinician-collected specimens (OTHER).

Who is sponsoring clinical trial NCT06776367?

This trial is sponsored by Biomedical Advanced Research and Development Authority, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06776367 being conducted?

This trial has 16 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.